Sun Pharma Q3 Results, Profit Slips 26 Percent

Sun Pharma Q3 Results, Profit Slips 26 Percent

Sun Pharma Q3 Results, Profit Slips 26 Percent

Sun Pharma Q3 Results, the company declared its Q3 earnings yesterday. The company’s consolidated profit declined 26.44 per cent year-on-year due to higher other expenses and decreased forex gain. In October to December quarter, the net profit stood at Rs 913.52 crore as against Rs 1,241.85 crore in the corresponding period a year ago. The net profit of the company failed to meet the analyst estimates. 

Meanwhile, the revenue from operations was at Rs 8,154.85 crore in Q3FY20, rose 5.36 per cent year-on-year. Whereas the company witnessed a 14.5 per cent year-on-year drop in EBITDA, stood at Rs 1,841.4 crore.  Margin contracted 520 bps to 22.6 per cent in December quarter, 2019. While the forex gain witnessed a fall of 64 per cent, stood at Rs 81.8 crore year-on-year in the third quarter ended on December 31 2019.

Getting into the more details of the Sun Pharma Q3 Results, other income also saw a drop of 37.9 per cent, stood at Rs 119.88 crore. But, the other expenses saw a rise of 22.86 per cent in Q3FY20, stood at Rs 2,646.14 crore as against the same quarter previous year. Sun Pharma said the board members announced an interim dividend of Rs 3 per share of Re 1 apiece for FY20. 

Related posts

Metal shares on April 21st; Hindalco Industries plunged almost 9%

Tarun

Stocks in news: Infosys, TCS, DCB Bank, Biocon, Adani Gas, Jet Airways

Tarun

Mphasis Q4 results: Net profit increased by 32% to Rs 353 crores for FY20

Tarun